Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
57.59
+2.19 (3.95%)
Sep 17, 2025, 2:14 PM EDT - Market open
Guardant Health Market Cap
Guardant Health has a market cap or net worth of $7.18 billion as of September 17, 2025. Its market cap has increased by 125.14% in one year.
Market Cap
7.18B
Enterprise Value
7.72B
1-Year Change
125.14%
Ranking
Category
Stock Price
$57.59
Market Cap Chart
Since October 4, 2018, Guardant Health's market cap has increased from $2.69B to $7.18B, an increase of 166.93%. That is a compound annual growth rate of 15.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 6.91B | 83.03% |
| Dec 31, 2024 | 3.77B | 14.96% |
| Dec 29, 2023 | 3.28B | 17.84% |
| Dec 30, 2022 | 2.79B | -72.60% |
| Dec 31, 2021 | 10.17B | -21.09% |
| Dec 31, 2020 | 12.88B | 75.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |